BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VTIMEZONE TZID:Pacific Standard Time X-LIC-LOCATION:America/Los_Angeles BEGIN:STANDARD DTSTART:20241103T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZNAME:PST TZOFFSETFROM:-0700 TZOFFSETTO:-0800 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250309T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZNAME:PDT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:2025 Annual Meeting by the Âé¶¹´«Ã½Ó³»­\n\nTi tle: Industry Therapeutic Update from Alexion\, AstraZeneca Rare Disease: Evolving our understanding of a complement inhibitor in anti-AChR antibo dy-positive gMG: Expert panel reviews pivotal study and long-term data…\n \nAccess URL: /MSA/Public/Events/GetEventURL/18292\n\n Learn More About This Event: /MSA/Public/Events/Detail s/18292 DTEND;TZID=Pacific Standard Time:20250409T124500 DTSTAMP:20260429T130921Z DTSTART;TZID=Pacific Standard Time:20250409T114500 LOCATION:/MSA/Public/Events/GetEventURL/18292 SEQUENCE:0 SUMMARY:Âé¶¹´«Ã½Ó³»­: Industry Therapeutic Update from Alexion\, AstraZeneca Rare D isease: Evolving our understanding of a complement inhibitor in anti-AChR antibody-positive gMG: Expert panel reviews pivotal study and long-term data… UID:43ffee9f-a6a3-47e2-bc58-c04270ae6603 END:VEVENT END:VCALENDAR